These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 1519828

  • 1. Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma.
    O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW.
    Am Rev Respir Dis; 1992 Sep; 146(3):560-4. PubMed ID: 1519828
    [Abstract] [Full Text] [Related]

  • 2. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
    Taylor DA, Jensen MW, Kanabar V, Engelstätter R, Steinijans VW, Barnes PJ, O'Connor BJ.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
    [Abstract] [Full Text] [Related]

  • 3. Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma.
    O'Connor BJ, Fuller RW, Barnes PJ.
    Am J Respir Crit Care Med; 1994 Aug; 150(2):381-7. PubMed ID: 8049819
    [Abstract] [Full Text] [Related]

  • 4. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [Abstract] [Full Text] [Related]

  • 5. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects.
    Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ.
    Am Rev Respir Dis; 1991 Jan; 143(1):109-13. PubMed ID: 1986667
    [Abstract] [Full Text] [Related]

  • 6. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW, van der Mark TW, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [Abstract] [Full Text] [Related]

  • 7. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
    Lipworth BJ, Sims EJ, Das SK, Buck H, Paterson M.
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
    [Abstract] [Full Text] [Related]

  • 8. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH, Worsdell M, Barnes PJ.
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [Abstract] [Full Text] [Related]

  • 9. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA, Jensen MW, Aikman SL, Harris JG, Barnes PJ, O'Connor BJ.
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [Abstract] [Full Text] [Related]

  • 10. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
    Rutgers SR, Koëter GH, van der Mark TW, Postma DS.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
    [Abstract] [Full Text] [Related]

  • 11. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
    Yates DH, Worsdell M, Barnes PJ.
    Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
    [Abstract] [Full Text] [Related]

  • 12. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW, Swystun VA, Bhagat R.
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide.
    Polosa R, Lau LC, Holgate ST.
    Eur Respir J; 1990 Jun; 3(6):665-72. PubMed ID: 2199209
    [Abstract] [Full Text] [Related]

  • 14. Minor acute effect of an inhaled corticosteroid (budesonide) on bronchial hyperresponsiveness to methacholine in children with asthma.
    van Essen-Zandvliet EE, Hop WC, de Jong H, Ferwerda A, Kerrebijn KF.
    Eur Respir J; 1993 Mar; 6(3):383-6. PubMed ID: 8472829
    [Abstract] [Full Text] [Related]

  • 15. Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness.
    Prieto L, Gutiérrez V, Cervera A, Liñana J.
    J Investig Allergol Clin Immunol; 2002 Mar; 12(2):91-8. PubMed ID: 12371536
    [Abstract] [Full Text] [Related]

  • 16. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
    Holgate ST, Arshad H, Stryszak P, Harrison JE.
    J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
    [Abstract] [Full Text] [Related]

  • 17. Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses.
    Manrique HA, Gómez FP, Muñoz PA, Peña AM, Barberà JA, Roca J, Rodríguez-Roisin R.
    Eur Respir J; 2008 Jun; 31(6):1205-12. PubMed ID: 18287126
    [Abstract] [Full Text] [Related]

  • 18. Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects.
    O'Connor BJ, Chung KF, Chen-Worsdell YM, Fuller RW, Barnes PJ.
    Am Rev Respir Dis; 1991 Jun; 143(6):1329-33. PubMed ID: 2048820
    [Abstract] [Full Text] [Related]

  • 19. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D, Vagaggini B, Bacci E, Fabbri LM, Giuntini C.
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
    [Abstract] [Full Text] [Related]

  • 20. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.